Pharmaceuticals
10 Johnson & Johnson finance leaders
These ten finance leaders hold or have held vice president and higher finance roles at Johnson & Johnson and its named businesses, including Johnson & Johnson's CFO, its corporate controller and CFOs of business units and regions. A reader can learn how CFOs approach planning, reporting and capital decisions in healthcare businesses.
Professionals to explore
01—10Bob Decker
LinkedInExperience: VP Corporate Controller & Chief Accounting Officer · Johnson & Johnson
VP Corporate Controller & Chief Accounting Officer at Johnson & Johnson since 2020, a role the profile lists at the President/Vice President level in Finance & Accounting. Former VP, Assistant Corporate Controller (2017–2020), CFO, VP Finance Johnson & Johnson Medical Devices North America (2015–2017) and CFO, VP Finance DePuy Synthes North America (2014–2015) at Johnson & Johnson.
Ellen Sipos
LinkedInExperience: CFO VP of Finance Enterprise Planning & Analysis · Johnson & Johnson
CFO VP of Finance Enterprise Planning & Analysis at Johnson & Johnson since 2021 and CFO VP of Finance, Enterprise Performance Management Strategy Transformation Leader there since June 2025. Former CFO Vice President of Finance for Johnson & Johnson Americas Financial Planning & Analysis (2019–2021) and CFO Vice President of Finance - Acquisitions & Divestitures Operations (2015–2018) at Johnson & Johnson.
Jennifer McIntyre
LinkedInExperience: CFO & VP of Finance, Technical Operations & Risk Management · Johnson & Johnson
Former CFO & VP of Finance, Technical Operations & Risk Management at Johnson & Johnson (2022–2026), where the profile describes providing financial support to the Executive VP, Chief Tech Ops and Risk Officer. CFO & VP Global Services Innovation Transformation Finance at Johnson & Johnson since August 2026, and former CFO & Vice President of Finance, Global Procurement there (2021–2022).
Jonathan Loane
LinkedInExperience: CFO, Vice President MedTech Center Finance · Johnson & Johnson
CFO, Vice President MedTech Center Finance at Johnson & Johnson since January 2025. Former CFO, Vice President of Finance, Global Medical Devices Supply Chain (2021–2025), Vice President, North America Global Services - Finance (2018–2021) and CFO, Johnson & Johnson Medical Companies (Canada) (2012–2015) at Johnson & Johnson.
Jose Luiz Azevedo
LinkedInExperience: Vice President of Finance, Chief Financial Officer, Vision · Johnson & Johnson
Vice President of Finance, Chief Financial Officer, Vision at Johnson & Johnson since July 2024. Former Vice President of Finance, Chief Financial Officer, Janssen Global R&D (2021–2024), Vice President, Finance and Chief Financial Officer Janssen Pharmaceutical North America (2019–2021) and Vice President, Finance, Johnson & Johnson Innovation (2017–2019) at Johnson & Johnson.
Joseph Wolk
LinkedInExperience: Executive Vice President, Chief Financial Officer · Johnson & Johnson
Executive Vice President, Chief Financial Officer at Johnson & Johnson since July 2018; the profile describes the job as stewarding Johnson & Johnson's financial health and helping people inside and outside the company understand the impact of its work. Former Vice President, Investor Relations (2016–2018) and CFO, Vice President, Finance - Global Pharmaceuticals (2014–2016) at Johnson & Johnson.
Mario Ballarin
LinkedInExperience: CFO & VP of Finance - J&J Innovative Medicine Latin America · Johnson & Johnson Innovative Medicine Latinoamérica
CFO & VP of Finance - J&J Innovative Medicine Latin America at Johnson & Johnson Innovative Medicine Latinoamérica since August 2025, a role the profile lists at the C-Level in Finance & Accounting. Former Country CFO - Senior Finance Director Brazil at Johnson & Johnson Innovative Medicine Brasil (2023–2025), and former Country CFO - Finance Director Mexico (2019–2023) and Regional Finance Director - Latin America (2018–2019) at Johnson & Johnson Innovative Medicine Latinoamérica.
Pascal Hoorn
LinkedInExperience: Chief Financial Officer, Vice President Finance J&J Innovative Medicine Principal Operations · Johnson & Johnson
Chief Financial Officer, Vice President Finance J&J Innovative Medicine Principal Operations at Johnson & Johnson since 2020; the profile headline adds finance transformation to the role. Former Chief Financial Officer, Executive Vice President at LifeScan (2018–2020) and former Sr. Director Finance & Operations EMEA, J&J Diabetes Care at Johnson & Johnson (2011–2018).
Salvatore Giovine
LinkedInExperience: CFO, VP Finance, Innovative Medicine North America · Johnson & Johnson
CFO, VP Finance, Innovative Medicine North America at Johnson & Johnson since November 2025, a role the profile lists at the C-Level in Finance & Accounting. Former Chief Financial Officer at Xilio Therapeutics, Inc. (2021–2022), and former Sr. Finance Director - U.S. Oncology Janssen Biotech, Inc. (2018–2021) and Sr. Finance Director - Venture Investments Johnson & Johnson Innovation - JJDC (2014–2018) at Johnson & Johnson.
Tracy Menkowski
LinkedInExperience: Chief Financial Officer, Vice President of Finance, Electrophysiology & Neurovascular · Johnson & Johnson
Chief Financial Officer, Vice President of Finance, Electrophysiology & Neurovascular at Johnson & Johnson since April 2025, a role the profile lists at the President/Vice President level. Former Senior Director, Investor Relations (2023–2025), Sr Finance Director & Commercial Finance Leader - Innovative Medicine North America (2022–2023) and Finance Director - Mergers & Acquisitions (2018–2022) at Johnson & Johnson.
Choose the right perspective
Match the person's scope to your question: the corporate CFO and controller suit questions about company-wide reporting, planning and capital allocation, while business-unit and regional CFOs suit questions about running finance for one franchise, function or geography. Check whether the relevant Johnson & Johnson role is current before asking about how finance works there today.
Questions to take into the conversation
- 01How do you split finance responsibilities between corporate finance and the CFOs of individual business units and regions?
- 02How does a large healthcare company plan and forecast across businesses with very different product cycles?
- 03What does finance look for when evaluating an acquisition, divestiture or major transformation program?
Reaching Johnson & Johnson finance leaders
How can I contact one of these Johnson & Johnson finance leaders?
Pick one of the 10 people on this page and choose "Book a paid call", or describe your project to find others. You offer a fee for a 15-minute call or a written answer, Instant Expert finds the person's work email and sends the invitation, and they decide whether to accept. The list covers 2 companies: Johnson & Johnson and Johnson & Johnson Innovative Medicine Latinoamérica, based on profile data retrieved on October 5, 2026. Being listed here doesn't mean someone has agreed to take calls.
How much does it cost to reach Johnson & Johnson finance leaders?
You choose the offer, starting at $5 per person. It includes Instant Expert's 20% fee, so an offer that pays the person $100 costs you $125. You're charged only when the person books the call or sends the answer.
What if they don't reply?
You pay nothing. Instant Expert sends follow-up reminders, and if the person hasn't booked or answered within 7 days, the request expires and any hold on your card is released. You can invite several of the 10 people on this list at once and cap your total spend, so you pay only for the ones who accept.
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot and may describe past or present roles. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.
Request a correction or removal